• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症患者心血管危险因素和疾病的患病率:一项基于人群的研究。

Prevalence of cardiovascular risk factors and disease in people with schizophrenia: a population-based study.

机构信息

School of Public Health, University of Alberta, Edmonton, Alberta, Canada.

出版信息

Schizophr Res. 2010 Mar;117(1):75-82. doi: 10.1016/j.schres.2009.12.016. Epub 2010 Jan 18.

DOI:10.1016/j.schres.2009.12.016
PMID:20080392
Abstract

OBJECTIVE

To evaluate the prevalence of cardiovascular risk factors (CV-RF) and disease (CV-D) in people with schizophrenia.

METHOD

We conducted a period-prevalence study using a population-based cohort from Alberta administrative databases. Schizophrenia was identified using billing codes; all other individuals served as non-schizophrenic controls. Modifiable CV-RF (hypertension, dyslipidemia, diabetes) and established CV-D (acute coronary syndrome (ACS), chronic ischemic heart disease (IHD), heart failure (HF), stroke, arrhythmia) were identified using previously validated methods. Analyses were conducted using multivariable logistic regression.

RESULTS

From 1995 to 2006, 28,755 people (1.2%) were identified with schizophrenia and compared with 2,281,636 non-schizophrenic controls. Individuals with schizophrenia were older (mean age 47.6 years vs. 45.3) and had lower socioeconomic status (59% received healthcare subsidies vs. 21%; OR: 5.55; 95% CI: 5.42-5.69) than controls. Of the CV-RF, diabetes was more common in those with schizophrenia than controls, particularly in younger males (ages 30-39, 3.8% vs. 1.4%, aOR: 1.57; 95% CI: 1.30-1.91) and females (ages 30-39, 5.8% vs. 2.4%, aOR: 1.72; 95% CI: 1.44-2.04). The prevalence of CV-D was significantly higher in people with schizophrenia than controls (27% vs. 17%, OR: 1.76; 95% CI: 1.72-1.81).

CONCLUSIONS

On a population-wide basis, people with schizophrenia had a higher prevalence of diabetes and cardiovascular disease than those without schizophrenia, particularly at a younger age. Female sex offered no cardiovascular protection in those with schizophrenia. Our data suggest monitoring for diabetes and other cardiovascular risk factors should begin at the time of diagnosis of schizophrenia, particularly in females with schizophrenia.

摘要

目的

评估精神分裂症患者心血管风险因素(CV-RF)和疾病(CV-D)的患病率。

方法

我们使用来自艾伯塔省行政数据库的基于人群的队列进行了一项现况研究。使用计费代码来识别精神分裂症;所有其他个体均作为非精神分裂症对照。使用先前验证过的方法来识别可改变的 CV-RF(高血压、血脂异常、糖尿病)和已确立的 CV-D(急性冠脉综合征(ACS)、慢性缺血性心脏病(IHD)、心力衰竭(HF)、中风、心律失常)。使用多变量逻辑回归进行分析。

结果

1995 年至 2006 年,共确定了 28755 名(1.2%)精神分裂症患者,并与 2281636 名非精神分裂症对照进行比较。精神分裂症患者年龄较大(平均年龄为 47.6 岁 vs. 45.3 岁),社会经济地位较低(59%接受医疗保健补贴 vs. 21%;OR:5.55;95%CI:5.42-5.69)。在心血管风险因素中,糖尿病在精神分裂症患者中比对照组更为常见,尤其是在年轻男性(30-39 岁,3.8% vs. 1.4%,aOR:1.57;95%CI:1.30-1.91)和女性(30-39 岁,5.8% vs. 2.4%,aOR:1.72;95%CI:1.44-2.04)中。与对照组相比,精神分裂症患者心血管疾病的患病率明显更高(27% vs. 17%,OR:1.76;95%CI:1.72-1.81)。

结论

在人群范围内,与非精神分裂症患者相比,精神分裂症患者的糖尿病和心血管疾病患病率更高,尤其是在更年轻的年龄。在精神分裂症患者中,女性没有提供心血管保护。我们的数据表明,特别是在患有精神分裂症的女性中,应在诊断为精神分裂症时开始监测糖尿病和其他心血管风险因素。

相似文献

1
Prevalence of cardiovascular risk factors and disease in people with schizophrenia: a population-based study.精神分裂症患者心血管危险因素和疾病的患病率:一项基于人群的研究。
Schizophr Res. 2010 Mar;117(1):75-82. doi: 10.1016/j.schres.2009.12.016. Epub 2010 Jan 18.
2
Diabetes, cardiovascular disease, and health care use in people with and without schizophrenia.糖尿病、心血管疾病与伴有和不伴有精神分裂症患者的医疗保健利用。
Eur Psychiatry. 2011 Jul-Aug;26(5):327-32. doi: 10.1016/j.eurpsy.2010.05.003. Epub 2010 Jul 14.
3
Utilization of general and specialized cardiac care by people with schizophrenia.精神分裂症患者对一般和专业心脏护理的利用。
Psychiatr Serv. 2012 Mar;63(3):237-42. doi: 10.1176/appi.ps.201000363.
4
Exploring the Distribution of Prescription for Sulfonylureas in Patients with Type 2 Diabetes According to Cardiovascular Risk Factors Within a Canadian Primary Care Setting.在加拿大基层医疗环境中,根据心血管危险因素探索2型糖尿病患者磺脲类药物处方的分布情况。
J Popul Ther Clin Pharmacol. 2015;22(3):e228-36. Epub 2015 Nov 11.
5
Risk of Major Cardiovascular Events in People with Down Syndrome.唐氏综合征患者发生重大心血管事件的风险
PLoS One. 2015 Sep 30;10(9):e0137093. doi: 10.1371/journal.pone.0137093. eCollection 2015.
6
Risk factors for cardiovascular disease in people with idiopathic pulmonary fibrosis: a population-based study.特发性肺纤维化患者心血管疾病的风险因素:一项基于人群的研究。
Chest. 2015 Jan;147(1):150-156. doi: 10.1378/chest.14-0041.
7
Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study.强直性脊柱炎患者心血管和脑血管疾病风险增加:一项基于人群的研究。
Arthritis Rheum. 2011 Nov;63(11):3294-304. doi: 10.1002/art.30581.
8
Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada.加拿大萨斯喀彻温省精神分裂症患者的心血管疾病
J Clin Psychiatry. 2004 May;65(5):715-20. doi: 10.4088/jcp.v65n0519.
9
[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].[制定重症精神疾病患者身体健康检查指南]
Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9.
10
Schizophrenia and the incidence of cardiovascular morbidity: a population-based longitudinal study in Ontario, Canada.精神分裂症与心血管发病率:加拿大安大略省的一项基于人群的纵向研究。
Schizophr Res. 2009 Dec;115(2-3):325-32. doi: 10.1016/j.schres.2009.07.018. Epub 2009 Sep 29.

引用本文的文献

1
Longitudinal trends in schizophrenia among older adults: a 12-year analysis of prevalence and healthcare utilization in South Korea.韩国老年人精神分裂症的纵向趋势:一项关于患病率和医疗保健利用情况的12年分析。
Schizophrenia (Heidelb). 2025 Feb 27;11(1):30. doi: 10.1038/s41537-025-00575-4.
2
Association between psychiatric disorders and the risk of stroke: a meta-analysis of cohort studies.精神障碍与中风风险之间的关联:队列研究的荟萃分析
Front Neurol. 2024 Dec 18;15:1444862. doi: 10.3389/fneur.2024.1444862. eCollection 2024.
3
Schizophrenia and type 2 diabetes risk: a systematic review and meta-analysis.
精神分裂症和 2 型糖尿病风险:系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2024 Sep 11;15:1395771. doi: 10.3389/fendo.2024.1395771. eCollection 2024.
4
Impact of institutional quality improvement initiatives on metabolic monitoring in mental disorder in patients treated with antipsychotics: A meta-analysis of intervention studies.改善医疗机构质量对接受抗精神病药物治疗的精神障碍患者代谢监测的影响:干预研究的荟萃分析。
J Glob Health. 2024 May 24;14:04074. doi: 10.7189/jogh.14.04074.
5
The PSY-SIM Model: Using Real-World Data to Inform Health Care Policy for Individuals With Chronic Psychotic Disorders.PSY-SIM 模型:利用真实世界数据为慢性精神病患者的医疗保健政策提供信息。
Schizophr Bull. 2024 Aug 27;50(5):1094-1103. doi: 10.1093/schbul/sbad175.
6
Insulin Resistance/Diabetes and Schizophrenia: Potential Shared Genetic Factors and Implications for Better Management of Patients with Schizophrenia.胰岛素抵抗/糖尿病与精神分裂症:潜在的共同遗传因素及对精神分裂症患者更好管理的意义
CNS Drugs. 2024 Jan;38(1):33-44. doi: 10.1007/s40263-023-01057-w. Epub 2023 Dec 14.
7
Hypercoagulable state in patients with schizophrenia: different effects of acute and chronic antipsychotic medications.精神分裂症患者的高凝状态:急性和慢性抗精神病药物的不同影响。
Ther Adv Psychopharmacol. 2023 Sep 27;13:20451253231200257. doi: 10.1177/20451253231200257. eCollection 2023.
8
Antipsychotics and Medical Comorbidity: A Retrospective Study in an Urban Outpatient Psychiatry Clinic.抗精神病药物与躯体共病:一项针对城市门诊精神科诊所的回顾性研究。
Community Ment Health J. 2023 May;59(4):641-653. doi: 10.1007/s10597-022-01045-2. Epub 2022 Nov 10.
9
Add-on exercise interventions for smoking cessation in people with mental illness: a systematic review and meta-analysis.针对患有精神疾病的人群进行戒烟的附加运动干预:一项系统评价与荟萃分析。
BMC Sports Sci Med Rehabil. 2022 Jun 21;14(1):115. doi: 10.1186/s13102-022-00498-y.
10
Determining Predictors of Weight Loss in a Behavioral Intervention: A Case Study in the Use of Lasso Regression.确定行为干预中体重减轻的预测因素:lasso回归应用的案例研究
Front Psychiatry. 2022 Feb 3;12:707707. doi: 10.3389/fpsyt.2021.707707. eCollection 2021.